Search

Your search keyword '"Dokken, Betsy"' showing total 125 results

Search Constraints

Start Over You searched for: Author "Dokken, Betsy" Remove constraint Author: "Dokken, Betsy"
125 results on '"Dokken, Betsy"'

Search Results

1. Extended Use of the Control-IQ Closed-Loop Control System in Children With Type 1 Diabetes.

9. Oxidative stress-induced insulin resistance in rat skeletal muscle: role of glycogen synthase kinase-3

10. A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes

11. Chronic selective glycogen synthase kinase-3 inhibition enhances glucose disposal and muscle insulin action in prediabetic obese Zucker rats

12. Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle

13. Defective insulin signaling in skeletal muscle of the hypertensive TG(mREN2)27 rat

14. Extended Use of the Control-IQ Closed-Loop Control System in Children With Type 1 Diabetes

15. The kidney as a treatment target for type 2 diabetes

16. Extended Use of the Control-IQ Closed-Loop Control System in Children With Type 1 Diabetes

18. The pathophysiology of cardiovascular disease and diabetes: beyond blood pressure and lipids

19. The physiology of body weight regulation: are we too efficient for our own good?

22. Reported insulin pump temperature fluctuations lack clinical relevance

25. Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes

26. The Parodox of glycemic control and cardiovascular complications: sorting out the data

27. Exceptional Usability of Tandem t:slim X2 with Basal-IQ Predictive Low-Glucose Suspend (PLGS)—The PROLOG Study

29. Reported insulin pump temperature fluctuations lack clinical relevance

30. Development and Testing of a Tissue Engineered Cardiac Construct for Treatment of Chronic Heart Failure

36. Combinatorial Targeting of the Glucagon-Like Peptide-1 And Sulfonylurea-1 Receptors Using a Complimentary Multivalent Glucagon-Like Peptide-1/Glibenclamide Ligand for the Improvement of β-Cell Targeting Agents and Diabetic Treatment

37. Preface

39. The Role of Glycogen Synthase Kinase-3 in Insulin-resistant Skeletal Muscle

40. Glucagon-like peptide-1 preserves coronary microvascular endothelial function after cardiac arrest and resuscitation: potential antioxidant effects

43. Glucagon‐like peptide‐1 (GLP‐1) improves coronary microvascular endothelial function after cardiac arrest and resuscitation and prevents anoxia‐induced coronary microvascular endothelial cell death

48. Planning for Sick Days, Surgery, and Travel.

50. Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulineresistant rat skeletal muscle.

Catalog

Books, media, physical & digital resources